Second Genome Announces Research Collaboration with Virginia Commonwealth University to Identify a Non-Invasive NASH Composite Biomarker

BRISBANE, Calif.: BRISBANE, Calif., Sept. 23, 2021 /PRNewswire/ -- Second Genome, a biotechnology company that leverages its proprietary platform sg-4sight to discover and develop precision therapies and biomarkers, today announced it entered into a research collaboration with Virginia Commonwealth University (VCU) to generate a non-invasive stool-based composite biomarker for non-alcoholic...

Click to view original post